Abstract
The aim of this investigation was to assess the antidiabetic properties of Anti-Diabetic
Churna using the streptozotocin-induced diabetes model, as well as its alpha amylase and
alpha glucosidase inhibitory activities.[1] One of particularly prevalent metabolic diseases,
diabetes mellitus affecting 2.8% of people worldwide and is projected to reach 5.4% by
2025. Herbal remedies have long been regarded as an extremely valuable form of
medicine; as a result, they are increasingly featured in cutting-edge, contemporary care.
Consequently, based on the review Medicinal plants’ ability to lower blood glucose levels is
mostly ascribed to the presence of polyphenols, flavonoids, terpenoids, coumarins, and
other components. Antidiabetic churna – a compound ayurvedic preparation made up of
Pterocarpus marsupium, Azardirachta indica, ocimum sanctum, syzygium cumini,
trigonella foenum graceum, emblica officinalis, glycyrrhiza glabra, curcuma longa, black
salt, piper nigrum, zingiber officinalis was screened for its antidiabetic activities.[2] Churna
was subjected to in vitro antidiabetic screening using the starch iodine and dinitro salicylic
acid (DNSA) methods, which involved α-amylase inhibition and IC 50 value was
calculated.[3] The powder characteristics performed like Ash value, Angle of repose,
Density, bulk density, tapped density, LOD, pH of churna. The standard limits have been
surpassed for each parameter